scispace - formally typeset
R

Ruth Dobson

Researcher at Queen Mary University of London

Publications -  176
Citations -  5112

Ruth Dobson is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Medicine & Multiple sclerosis. The author has an hindex of 26, co-authored 116 publications receiving 3351 citations. Previous affiliations of Ruth Dobson include Manchester Academic Health Science Centre & Royal London Hospital.

Papers
More filters
Journal ArticleDOI

Multiple Sclerosis - A Review

TL;DR: The epidemiology of MS indicates that low serum levels of vitamin D, smoking, childhood obesity and infection with the Epstein–Barr virus are likely to play a role in disease development, and potentially preventive strategies could be studied.
Journal ArticleDOI

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

TL;DR: Identifying and studying individuals with a high risk of developing the disease provides a powerful opportunity to understand the MS causal cascade and is highly relevant to strategies that are aimed at preventing this debilitating disease.
Journal ArticleDOI

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

TL;DR: The data supports further longitudinal studies of serum NfL in neurodegenerative diseases as a potential biomarker of on-going disease progression, and as a possible surrogate to quantify effects of neuroprotective drugs in clinical trials.
Journal ArticleDOI

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude

TL;DR: OCB positivity strongly predicts conversion from CIS to MS, and the relationship between latitude and OCBs is confirmed, and this finding warrants further investigation.
Journal ArticleDOI

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kuhle, +98 more
TL;DR: MRI lesion load, OCB and age at CIS are validated as the strongest independent predictors of conversion to CDMS in this multicentre setting.